Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, Via Fossato di Mortara 66, 44121 Ferrara, Italy.
Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Via dell'Istria 65/01, 34137 Trieste, Italy.
J Immunol Res. 2014;2014:473765. doi: 10.1155/2014/473765. Epub 2014 Mar 25.
The expression of proinflammatory cytokines/chemokines has been reported in in vitro/ex vivo settings of chronic venous insufficiency (CVI), but the identification of circulating mediators that might be associated with altered hemodynamic forces or might represent innovative biomarkers is still missing. In this study, the circulating levels of 31 cytokines/chemokines involved in inflammatory/angiogenic processes were analysed in (i) CVI patients at baseline before surgical hemody namic correction, (ii) healthy subjects, and (iii) CVI patients after surgery. In a subgroup of CVI patients, in whom the baseline levels of cytokines/chemokines were analyzed in paired blood samples obtained from varicose vein and forearm vein, EGF, PDGF, and RANTES were increased at the varicose vein site as compared to the general circulation. Moreover, while at baseline, CVI patients showed increased levels of 14 cytokines/chemokines as compared to healthy subjects, 6 months after surgery, 11 cytokines/chemokines levels were significantly reduced in the treated CVI patients as compared to the CVI patients before surgery. Of note, a patient who exhibited recurrence of the disease 6 months after surgery, showed higher levels of EGF, PDGF, and RANTES compared to nonrecurrent patients, highlighting the potential role of the EGF/PDGF/RANTES triad as sensitive biomarkers in the context of CVI.
在慢性静脉功能不全(CVI)的体外/离体环境中已经报道了促炎细胞因子/趋化因子的表达,但仍然缺乏与改变的血流动力相关的循环介质或可能代表创新生物标志物的鉴定。在这项研究中,分析了(i)在手术血流动力学矫正之前的基线时的 CVI 患者、(ii)健康受试者和(iii)手术后的 CVI 患者中涉及炎症/血管生成过程的 31 种细胞因子/趋化因子的循环水平。在 CVI 患者的亚组中,对从静脉曲张和前臂静脉获得的配对血样进行了细胞因子/趋化因子的基线水平分析,与一般循环相比,在静脉曲张部位 EGF、PDGF 和 RANTES 增加。此外,虽然 CVI 患者在基线时与健康受试者相比表现出 14 种细胞因子/趋化因子水平升高,但在手术后 6 个月时,与手术前的 CVI 患者相比,11 种细胞因子/趋化因子水平在接受治疗的 CVI 患者中显著降低。值得注意的是,在手术后 6 个月时疾病复发的患者与非复发患者相比,EGF、PDGF 和 RANTES 的水平更高,突出了 EGF/PDGF/RANTES 三联体作为 CVI 背景下敏感生物标志物的潜在作用。